Abbvie Clinical Trials for Myelofibrosis and Acute Myeloid Leukemia

  • June 30, 2022


  1. Transform-1 (M16-191)
    1. Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis
    2. FL sites:
      1. Lynn Cancer Institute in Boca
      2. FCS South
  • FCS East
  1. FCS North
  1. gov:

Acute Myeloid Leukemia

  1. Viale-T (M19-063)
    1. Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell Transplantation in Subjects With AML
    2. FL sites:
      1. AdventHealth Orlando
      2. Mayo Clinic Jacksonville (not active)
    3. gov:
  2. Viale-M (M19-708)
    1. Phase 3 Study of Venetoclax and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy for Patients With AML in First Remission After Conventional Chemotherapy
    2. FL sites:
      1. Baptist MD Anderson Cancer Center in Jacksonville (not active)
    3. gov:

© 2021 FLASCO | Premium Website Design by The HDG